These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3052118)

  • 1. Iron chelators: in vitro inhibitory effect on the liver stage of rodent and human malaria.
    Stahel E; Mazier D; Guillouzo A; Miltgen F; Landau I; Mellouk S; Beaudoin RL; Langlois P; Gentilini M
    Am J Trop Med Hyg; 1988 Sep; 39(3):236-40. PubMed ID: 3052118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium falciparum and Plasmodium yoelii: effect of the iron chelation prodrug dexrazoxane on in vitro cultures.
    Loyevsky M; Sacci JB; Boehme P; Weglicki W; John C; Gordeuk VR
    Exp Parasitol; 1999 Feb; 91(2):105-14. PubMed ID: 9990337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The desferrithiocin (DFT) class of iron chelators: potential as antineoplastic agents.
    Kicic A; Chua AC; Baker E
    Anticancer Drug Des; 2001; 16(4-5):195-207. PubMed ID: 12049478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desferrithiocin is a more potent antineoplastic agent than desferrioxamine.
    Kicic A; Chua AC; Baker E
    Br J Pharmacol; 2002 Mar; 135(6):1393-402. PubMed ID: 11906952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial iron chelator, FBS0701, shows asexual and gametocyte Plasmodium falciparum activity and single oral dose cure in a murine malaria model.
    Ferrer P; Tripathi AK; Clark MA; Hand CC; Rienhoff HY; Sullivan DJ
    PLoS One; 2012; 7(5):e37171. PubMed ID: 22629364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron chelators: correlation between effects on Plasmodium spp. and immune functions.
    Golenser J; Domb A; Mordechai-Daniel T; Leshem B; Luty A; Kremsner P
    J Parasitol; 2006 Feb; 92(1):170-7. PubMed ID: 16629332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of tridentate iron chelators: from desferrithiocin to ICL670.
    Nick H; Acklin P; Lattmann R; Buehlmayer P; Hauffe S; Schupp J; Alberti D
    Curr Med Chem; 2003 Jun; 10(12):1065-76. PubMed ID: 12678677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A non-human primate model for the study of oral iron chelators.
    Wolfe LC; Nicolosi RJ; Renaud MM; Finger J; Hegsted M; Peter H; Nathan DG
    Br J Haematol; 1989 Jul; 72(3):456-61. PubMed ID: 2765410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of desferrithiocin, an oral iron chelator, on T-cell function.
    Bierer BE; Nathan DG
    Blood; 1990 Nov; 76(10):2052-9. PubMed ID: 2242426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A plant-derived morphinan as a novel lead compound active against malaria liver stages.
    Carraz M; Jossang A; Franetich JF; Siau A; Ciceron L; Hannoun L; Sauerwein R; Frappier F; Rasoanaivo P; Snounou G; Mazier D
    PLoS Med; 2006 Dec; 3(12):e513. PubMed ID: 17194195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria.
    Pattanapanyasat K; Thaithong S; Kyle DE; Udomsangpetch R; Yongvanitchit K; Hider RC; Webster HK
    Cytometry; 1997 Jan; 27(1):84-91. PubMed ID: 9000589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium falciparum: inhibition of in vitro growth by desferrioxamine.
    Raventos-Suarez C; Pollack S; Nagel RL
    Am J Trop Med Hyg; 1982 Sep; 31(5):919-22. PubMed ID: 6751113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimalarial effect of iron chelators.
    Gordeuk VR; Loyevsky M
    Adv Exp Med Biol; 2002; 509():251-72. PubMed ID: 12572998
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential cytotoxicity of iron chelators on malaria-infected cells versus mammalian cells.
    Glickstein H; Breuer W; Loyevsky M; Konijn AM; Shanzer A; Cabantchik ZI
    Blood; 1996 Jun; 87(11):4871-8. PubMed ID: 8639861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimalarial iron chelator FBS0701 blocks transmission by Plasmodium falciparum gametocyte activation inhibition.
    Ferrer P; Vega-Rodriguez J; Tripathi AK; Jacobs-Lorena M; Sullivan DJ
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1418-26. PubMed ID: 25512427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desferrithiocin.
    Wolfe LC
    Semin Hematol; 1990 Apr; 27(2):117-20. PubMed ID: 2349483
    [No Abstract]   [Full Text] [Related]  

  • 17. Desferrithiocin is an effective iron chelator in vivo and in vitro but ferrithiocin is toxic.
    Baker E; Wong A; Peter H; Jacobs A
    Br J Haematol; 1992 Jul; 81(3):424-31. PubMed ID: 1340769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profiles.
    Bergeron RJ; Wiegand J; Bharti N; McManis JS
    J Med Chem; 2012 Aug; 55(16):7090-103. PubMed ID: 22889170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desferrioxamine suppresses Plasmodium falciparum in Aotus monkeys.
    Pollack S; Rossan RN; Davidson DE; Escajadillo A
    Proc Soc Exp Biol Med; 1987 Feb; 184(2):162-4. PubMed ID: 3543939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium falciparum: inhibition in vitro with lactoferrin, desferriferrithiocin, and desferricrocin.
    Fritsch G; Sawatzki G; Treumer J; Jung A; Spira DT
    Exp Parasitol; 1987 Feb; 63(1):1-9. PubMed ID: 3542546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.